retatrutide what is it clinical trials trial information Safety, Side Effects & Provider Use Retatrutide Dosing: Early Clinical Trial – Retatrutide UK: 2026 Clinical Trial

Peritoneal Dialysis Although observational data have suggested that patients treated with PD may have lower ESA requirements than HD patients, 255,256 no controlled trials have been reported comparing HD and PD or different doses of PD on anemia outcomes or ESA dose in ESA-treated patients

GLP-1 drugs, particularly semaglutide, have been shown to support weight loss, which might improve overall health and potentially reduce the burden of lupus symptoms

Strength training helps preserve muscle mass and supports bone health, which are both important considerations during weight loss

Participants also lost significantly more weight on semaglutide than placebo